Occupational Therapists in Austintown, OH Accepting Medicare

9 Occupational Therapists found. Showing 1 - 9

Renee L Harshbarger, ORT,L Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 45 N Canfield Niles Rd, Austintown, OH 44515 Phone: 330-518-2215

Kathy C Laughner Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 755 Ohltown Rd, Austintown, OH 44515 Phone: 330-505-0585

Kelsey Mosinski, MS, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 5533 Mahoning Ave Fl 2, Austintown, OH 44515 Phone: 330-480-3533

Mahoning Valley Hand Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 45 N Canfield Niles Rd, Austintown, OH 44515 Phone: 330-204-1217    Fax: 440-985-3308

Alexandra Marie Zubyk, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 5533 Mahoning Ave Fl 2, Austintown, OH 44515 Phone: 330-799-0094    Fax: 330-799-8303

Charlotte Ann Rocca Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 755 Ohltown Rd, Austintown, OH 44515 Phone: 330-505-0585

Kimberly Dianne Zeidenstein, MHA, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4780 Kirk Rd, Austintown, OH 44515 Phone: 330-792-7681

Erin Michelle Rodgers, COTA/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 331 N. Yorkshire Blvd., Austintown, OH 44515 Phone: 330-707-6132

Kelly Elizabeth Musick Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 755 Ohltown Rd, Austintown, OH 44515 Phone: 339-505-0144

News Archive

USFDA approves Dr. Reddy's ANDA for Fondaparinux Sodium Injection

Dr. Reddy's Laboratories and Alchemia Limited, Brisbane, Australia announced today that Dr. Reddy's has received final approval of Dr. Reddy's ANDA for Fondaparinux Sodium Injection, a bioequivalent generic version of Arixtra, in the US market on July 11, 2011 by the United States Food & Drug Administration.

Takeda, SPI announce that lubiprostone phase 3 trial on OBD meets primary endpoint

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic, non-cancer pain, excluding those taking methadone.

Surgical hubs, new technology key to tackling the growing NHS waiting lists

Local surgical hubs, new technology to speed up diagnosis, and innovative ways of working will help the NHS to tackle growing waiting lists and treat around 30% more patients who need elective care by 2023/24.

Surgeon General report reveals increasing rate of electronic cigarette use among adolescents

The United States Surgeon General recently issued a report that adolescents' use of electronic cigarettes has more than tripled since 2011. As recently as 2010, e-cigarettes were rare, but in 2015, 40 percent of high school students said they had used e-cigarettes at least once and 16 percent reported that they used such products in the past 30 days.

Read more Medical News

› Verified 6 days ago